Literature DB >> 26887428

Effect of Human Umbilical Cord Mesenchymal Stem Cell Transplantation in a Rat Model of Preeclampsia.

Lei-Lei Wang1, Yang Yu1, Hong-Bo Guan1, Chong Qiao2.   

Abstract

OBJECTIVE: To test the effects of human umbilical cord mesenchymal stem cell (HU-MSC) transplantation on reversing preeclampsia (PE) symptoms in a lipopolysaccharide (LPS)-induced rat PE model.
METHODS: Human umbilical cord MSCs were detected, isolated, and cultured. Human umbilical cord MSC transplantation was conducted. Expressions of inflammatory cytokines in serum and placental tissue were measured by enzyme-linked immunosorbent assay. Changes in inflammatory cytokines, peroxisome proliferator-activated receptor γ (PPARγ), laminin receptor 1 (LR1), matrix metalloproteinase (MMP) 2, and MMP-9 messenger RNA (mRNA) levels in placental tissue were recorded by quantitative real-time polymerase chain reaction. Immunohistochemistry and Western blotting were performed for PPARγ detection.
RESULTS: The LPS group exhibited increased blood pressure and proteinuria and decreased fetal weight compared to the normal pregnancy (NP) group (all P < .05). The LPS + MSC group presented lowered blood pressure and higher fetal weight than the LPS group (P < .05). The levels of interferon γ, tumor necrosis factor α (TNF-α), interleukin (IL) 1β, IL-6, IL-8, IL-12, and intercellular adhesion molecule 1 (ICAM-1) increased and the levels of IL-4 and IL-10 levels decreased in the LPS group compared to the NP group (all P < .05). Tumor necrosis factor α, IL-6, IL-12, and ICAM-1 levels decreased and IL-10 level increased in the LPS + MSC group compared to the LPS group (all P < .05). The LPS-MSC group showed lower mRNA expressions of TNF-α, IL-6, MMP-2, MMP-9, and ICAM-1 and higher mRNA expressions of IL-10, PPARγ, and LR1 than the LPS group (all P < .05).
CONCLUSION: In summary, HU-MSC transplantation may be extremely beneficial for PE therapy.
© The Author(s) 2016.

Entities:  

Keywords:  gestational hypertension; human umbilical cord mesenchymal stem cells; preeclampsia

Mesh:

Substances:

Year:  2016        PMID: 26887428     DOI: 10.1177/1933719116630417

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  12 in total

Review 1.  The pathological and therapeutic roles of mesenchymal stem cells in preeclampsia.

Authors:  Sanshan Jin; Canrong Wu; Ming Chen; Dongyan Sun; Hua Zhang
Journal:  Front Med (Lausanne)       Date:  2022-07-28

Review 2.  Targeted drug delivery for maternal and perinatal health: Challenges and opportunities.

Authors:  Anjali Sharma; Nirnath Sah; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Adv Drug Deliv Rev       Date:  2021-08-26       Impact factor: 17.873

3.  Preeclamptic Women Have Decreased Circulating IL-10 (Interleukin-10) Values at the Time of Preeclampsia Diagnosis: Systematic Review and Meta-Analysis.

Authors:  Meryl C Nath; Hajrunisa Cubro; Daniel J McCormick; Natasa M Milic; Vesna D Garovic
Journal:  Hypertension       Date:  2020-10-26       Impact factor: 10.190

Review 4.  The Role of Interleukin-10 in the Pathophysiology of Preeclampsia.

Authors:  Hajrunisa Cubro; Sonu Kashyap; Meryl C Nath; Allan W Ackerman; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2018-04-30       Impact factor: 5.369

Review 5.  Emerging Therapeutic Potential of Mesenchymal Stem/Stromal Cells in Preeclampsia.

Authors:  S Suvakov; C Richards; V Nikolic; T Simic; K McGrath; A Krasnodembskaya; L McClements
Journal:  Curr Hypertens Rep       Date:  2020-04-14       Impact factor: 5.369

6.  Potential biological therapies for severe preeclampsia: a systematic review and meta-analysis.

Authors:  Sophia Grimes; Kira Bombay; Andrea Lanes; Mark Walker; Daniel J Corsi
Journal:  BMC Pregnancy Childbirth       Date:  2019-05-09       Impact factor: 3.007

7.  Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment.

Authors:  Naomi Todd; Ross McNally; Abdelrahim Alqudah; Djurdja Jerotic; Sonja Suvakov; Danilo Obradovic; Denise Hoch; Jose R Hombrebueno; Guillermo Lopez Campos; Chris J Watson; Miroslava Gojnic-Dugalic; Tatjana P Simic; Anna Krasnodembskaya; Gernot Desoye; Kelly-Ann Eastwood; Alyson J Hunter; Valerie A Holmes; David R McCance; Ian S Young; David J Grieve; Louise C Kenny; Vesna D Garovic; Tracy Robson; Lana McClements
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

8.  Effect of Placenta-Derived Mesenchymal Stromal Cells Conditioned Media on an LPS-Induced Mouse Model of Preeclampsia.

Authors:  Anna Maria Nuzzo; Laura Moretti; Paolo Mele; Tullia Todros; Carola Eva; Alessandro Rolfo
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

Review 9.  Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility.

Authors:  Sahar Esfandyari; Rishi Man Chugh; Hang-Soo Park; Elie Hobeika; Mara Ulin; Ayman Al-Hendy
Journal:  Cells       Date:  2020-10-08       Impact factor: 6.600

Review 10.  Role of Extracellular Vesicles in Placental Inflammation and Local Immune Balance.

Authors:  Zengfang Wang; Ruizhen Yang; Jiaojiao Zhang; Pingping Wang; Zengyan Wang; Jian Gao; Xue Liu
Journal:  Mediators Inflamm       Date:  2021-06-18       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.